Leonor Moreno Núñez,Cristina Garmendia Fernández,Manuel Ruiz Muñoz et al.
Leonor Moreno Núñez et al.
Objective: To evaluate the adequacy of empirical antibiotic prescription and the duration of antibiotic therapy for infected patients admitted for conventional hospitalization (CH) and Hospitalization at Home (HaH) after ...
Impact of EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) on optimal antimicrobial therapy in gram-negative bloodstream infections [0.03%]
EUCAST快速抗菌素敏感性测试(RAST)对革兰氏阴性菌血流感染的最佳抗微生物治疗的影响
Özge Özgen Top,Beyza Çifci,Merve Büyükkörük et al.
Özge Özgen Top et al.
Objectives: To evaluate the possible impact of RAST on optimal antimicrobial therapy via de-escalation or escalation, and to determine the reduction in antibiotic susceptibility reporting time with RAST. ...
Antibiotic shortages [0.03%]
抗生素短缺问题
Robert Cohen,Remy Gauzit,Jean Paul Stahl
Robert Cohen
Dual detection of Neoehrlichia mikurensis and Anaplasma phagocytophilum: How biplex PCR led in France to the diagnosis of neoehrlichiosis in post-tick bite fever [0.03%]
Neoehrlichia mikurensis和安第斯毕氏体的双重检测：法国双联PCR在蜱咬热后的neoehrlichiosis诊断中的应用
Martin Martinot,Marc Astrie,Mahsa Mohseni-Zadeh et al.
Martin Martinot et al.
Objectives: Neoehrlichia mikurensis (NM) is an emerging intracellular bacterium member of the Anaplasmatacecae family. So far, only four cases have been described in France, all of them retrospectively. ...
Clostridium symbiosum: A novel pathogen causing central nervous system infections in encephalitis patients [0.03%]
芽孢杆菌新成员——引起脑炎患者中枢神经系统感染的新型病原体
Jinhua Zhang,Bei Wang,Jingjing Wang et al.
Jinhua Zhang et al.
Changes in early HIV/AIDS mortality rates in people initiating antiretroviral treatment between 2013 and 2023: A 10-year multicenter survival study in Senegal [0.03%]
2013年至2023年塞内加尔开始接受抗逆转录病毒治疗的人群中艾滋病早期死亡率变化的十年多中心生存研究
Bruce Shinga Wembulua,Viviane Marie Pierre Cisse,Daye Ka et al.
Bruce Shinga Wembulua et al.
Background: HIV/AIDS-related early mortality has long been a significant challenge. Subsequent to recent policy changes and treatment advancements, we aimed to assess changes in early mortality rates in 2017-19 and 2020-2...
Multicenter Study
Infectious diseases now. 2024 Dec;54(8):104990. DOI:10.1016/j.idnow.2024.104990 2024
The emergence of streptococcal epiglottitis in adults amid Increasing iGAS cases [0.03%]
成人链球菌性会厌炎在iGAS病例增加期间的出现
Giorgos Sideris,Evangelos Panagoulis,Nikolaos Papadimitriou et al.
Giorgos Sideris et al.
Outcomes of low-dose trimethoprim-sulfamethoxazole treatment in patients with non-HIV pneumocystis pneumonia: A nationwide Japanese retrospective cohort study [0.03%]
日本全国非艾滋病相关肺炎支原体肺炎患者低剂量复方新诺明治疗的结局：一项基于回顾性队列的研究
Jumpei Taniguchi,Shotaro Aso,Taisuke Jo et al.
Jumpei Taniguchi et al.
Objectives: Low-dose trimethoprim-sulfamethoxazole (TMP-SMX) may be a treatment option for patients with Pneumocystis jirovecii pneumonia (PCP). However, its effectiveness in patients without human immunodeficiency virus ...
A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia [0.03%]
替诺福韦或拉米夫定间歇疗法维持HBV/HIV共感染且病毒载量低的患者HBV病毒学抑制的病例报告系列研究
S Seang,P Detruchis,E Todesco et al.
S Seang et al.
Objective: To describe the efficacy of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in HBV/HIV-1 patients. ...
Observational Study
Infectious diseases now. 2024 Oct;54(7):104980. DOI:10.1016/j.idnow.2024.104980 2024
Doutchi Mahamadou,Adamou Bara Abdoul-Aziz,Lamine Mahaman Moustapha et al.
Doutchi Mahamadou et al.
Background: Diphtheria is a re-emerging bacterial disease in developing countries with low vaccination coverage. Objectives: This is a ...